Home/Filings/4/0001104659-23-018835
4//SEC Filing

Burton Freya 4

Accession 0001104659-23-018835

CIK 0001843724other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 9:24 PM ET

Size

51.5 KB

Accession

0001104659-23-018835

Insider Transaction Report

Form 4
Period: 2023-02-08
Burton Freya
Chief Sustainability Officer
Transactions
  • Award

    Stock Options

    2023-02-08+20,00020,000 total(indirect: By Spouse)
    Exercise: $1.60Exp: 2024-07-14Common Stock (87,493 underlying)
  • Award

    Stock Options

    2023-02-08+20,00020,000 total(indirect: By Spouse)
    Exercise: $1.52Exp: 2026-02-12Common Stock (87,493 underlying)
  • Award

    Stock Options

    2023-02-08+47,10247,102 total(indirect: By Spouse)
    Exercise: $1.38Exp: 2026-10-13Common Stock (206,056 underlying)
  • Award

    Stock Options

    2023-02-08+8,4928,492 total
    Exercise: $1.64Exp: 2029-04-18Common Stock (37,149 underlying)
  • Award

    Stock Options

    2023-02-08+30,00030,000 total
    Exercise: $1.07Exp: 2030-06-26Common Stock (131,240 underlying)
  • Award

    Stock Options

    2023-02-08+30,75230,752 total(indirect: By Spouse)
    Exercise: $1.07Exp: 2030-06-26Common Stock (134,530 underlying)
  • Award

    Stock Options

    2023-02-08+19,24819,248 total(indirect: By Spouse)
    Exercise: $1.07Exp: 2030-06-26Common Stock (84,203 underlying)
  • Award

    Stock Options

    2023-02-08+10,00010,000 total
    Exercise: $1.52Exp: 2025-05-06Common Stock (43,746 underlying)
  • Award

    Common Stock

    2023-02-08+33,34633,346 total
  • Award

    Stock Options

    2023-02-08+20,00020,000 total
    Exercise: $1.52Exp: 2026-02-12Common Stock (87,493 underlying)
  • Award

    Stock Options

    2023-02-08+41,68541,685 total
    Exercise: $1.38Exp: 2027-09-20Common Stock (182,358 underlying)
  • Award

    Stock Options

    2023-02-08+64,00064,000 total(indirect: By Spouse)
    Exercise: $1.38Exp: 2027-09-20Common Stock (279,979 underlying)
  • Award

    Stock Options

    2023-02-08+38,31538,315 total
    Exercise: $1.38Exp: 2027-09-20Common Stock (167,615 underlying)
  • Award

    Stock Options

    2023-02-08+20,00020,000 total
    Exercise: $1.38Exp: 2026-10-13Common Stock (87,493 underlying)
  • Award

    Stock Options

    2023-02-08+32,89832,898 total(indirect: By Spouse)
    Exercise: $1.38Exp: 2026-10-13Common Stock (143,918 underlying)
  • Award

    Stock Options

    2023-02-08+11,50811,508 total
    Exercise: $1.64Exp: 2029-04-18Common Stock (50,343 underlying)
  • Award

    Stock Options

    2023-02-08+20,00020,000 total
    Exercise: $1.07Exp: 2030-06-26Common Stock (87,493 underlying)
  • Award

    Stock Options

    2023-02-08+1,8321,832 total
    Exercise: $1.07Exp: 2030-11-09Common Stock (8,014 underlying)
  • Award

    Stock Options

    2023-02-08+125125 total
    Exercise: $1.07Exp: 2030-11-09Common Stock (546 underlying)
  • Award

    Stock Options

    2023-02-08+3,2003,200 total(indirect: By Spouse)
    Exercise: $1.38Exp: 2027-09-20Common Stock (13,998 underlying)
  • Award

    Stock Options

    2023-02-08+12,80012,800 total(indirect: By Spouse)
    Exercise: $1.38Exp: 2027-09-20Common Stock (55,995 underlying)
  • Award

    Stock Options

    2023-02-08+420420 total
    Exercise: $1.07Exp: 2030-11-09Common Stock (1,837 underlying)
Footnotes (6)
  • [F1]On February 8, 2023, AMCI Acquisition Corp. II ("AMCI") consummated a business combination (the "Business Combination") by and among AMCI, AMCI Merger Sub, Inc., a Delaware corporation ("AMCI Merger Sub") and LanzaTech NZ, Inc., a Delaware corporation ("Legacy LanzaTech"), AMCI changed its name to "LanzaTech Global, Inc." and AMCI Merger Sub merged with and into Legacy LanzaTech. As part of the Business Combination, each share of Legacy LanzaTech stock was exchanged for 4.374677 shares of common stock of LanzaTech Global, Inc.
  • [F2]Options are fully vested and exercisable.
  • [F3]492 the options vested on on April 18, 2022, the remaining options vest annually thereafter over the remaining two years.
  • [F4]752 the options vested on on January 1, 2022, the remaining options vest annually thereafter over the remaining three years.
  • [F5]10,000 of the options vested on January 1, 2023, the remaining options vest annually thereafter over the remaining two years.
  • [F6]As part of the Business Combination, each Legacy LanzaTech stock option was exchanged for a stock option to acquire 4.374677 shares of common stock of LanzaTech Global, Inc.

Issuer

LanzaTech Global, Inc.

CIK 0001843724

Entity typeother

Related Parties

1
  • filerCIK 0001963301

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 9:24 PM ET
Size
51.5 KB